Search Within

Alumni (GSK)

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (215)
  2. Meeting Abstract (106)
  3. Research Letter (4)
  4. Editorial (2)
  5. Review (2)
  6. Book Section (1)
Groups
  1. GSK Faculty (330)
  2. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (330)
  3. Human Oncology and Pathogenesis Program (330)
  4. Department of Medicine (299)
  5. Sloan Kettering Institute Postdocs (242)
  6. Center for Hematologic Malignancies (200)

More Groups

People
  1. Ross Levine (123)
  2. Michael Berger (53)
  3. David Solit (50)
  4. Nikolaus Schultz (46)
  5. Marc Ladanyi (38)
  6. Robert Bowman (32)

More People

Years
  1. 2025 (6)
  2. 2024 (22)
  3. 2023 (34)
  4. 2022 (38)
  5. 2021 (26)
  6. 2020 (30)

More Years

Publications
  1. Blood (45)
  2. Cancer Research (35)
  3. Cancer Discovery (22)
  4. Clinical Cancer Research (19)
  5. Cancer Cell (16)
  6. Journal of Clinical Oncology (15)

More Publications

Publishers
  1. American Association for Cancer Research (83)
  2. Nature Publishing Group (51)
  3. American Society of Hematology (46)
  4. Cell Press (38)
  5. American Society of Clinical Oncology (20)
  6. National Academy of Sciences (9)

More Publishers

Results (330)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
    Journal Article

    Kleppe, M.; Kwak, M.; Koppikar, P.; Riester, M.; Keller, M.; Bastian, L.; Hricik, T.; Bhagwat, N.; McKenney, A. S.; Papalexi, E.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • BRAF mutations in human cancer: Biologic and therapeutic implications
    Book Section

    Nissan, M. H.; Solit, D. B.
    In Gelmann, E. P.; Sawyers, C. L.; Rauscher, F. J. 3rd (Eds.) Molecular Oncology: Causes of Cancer and Targets for Treatment (2014)

    Fulltext@MSK | Save
  • Dual lineage inhibition of ETV1 and KIT disrupts the ETV1-KIT feed forward circuit and potentiates imatinib antitumor effect in GIST oncogenesis
    Meeting Abstract

    Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Rossi, F.; Wongvipat, J.; Tap, W. D.; Besmer, P.; Antonescu, C. R.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Mathematical optimization of JAK inhibitor dose and scheduling for MPN patients
    Meeting Abstract

    Shank, K. R.; Koppikar, P.; Bhagwat, N.; Keller, M. D.; Michor, F.; Levine, R. L.; Roditi, L. D.
    Blood (2014)

    Fulltext@MSK | Save
  • Msi2 maintains the MLL leukemia stem cell regulatory program
    Meeting Abstract

    Park, S. M.; Gonen, M.; Vu, L. P.; Minuesa, G.; Tivnan, P.; Barlowe, T.; Taggart, J.; Lu, Y. H.; Deering, R. P.; Hacohen, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Mechanistic investigations of leptomeningeal metastasis from solid tumors
    Meeting Abstract

    Boire, A.; Zou, Y. L.; DeAngelis, L.; Massague, J.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
    Journal Article

    Rampal, R.; Ahn, J.; Abdel-Wahab, O.; Nahas, M.; Wang, K.; Lipson, D.; Otto, G. A.; Yelensky, R.; Hricik, T.; McKenney, A. S.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2014)

    Fulltext@MSK | Save
  • Genetic studies reveal Jak2 is not essential for platelet production
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Woods, B. A.; LaFave, L. M.; Bastian, L.; Kleppe, M.; Bhagwat, N.; Marubayashi, S.; Levine, R. L.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Acceleration of BCR-ABL+ leukemia induced by deletion of JAK2
    Meeting Abstract

    Grundschober, E.; Hoelbl-Kovacic, A.; Bhagwat, N.; Levine, R.; Sexl, V.
    Haematologica (2014)

    Fulltext@MSK | Save